Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis grabs an option to buy biotech startup for up to $300M
Novartis grabs an option to buy biotech startup for up to $300M
Novartis grabs an option to buy biotech startup for up to $300M
Submitted by
admin
on October 22, 2013 - 11:43am
Source:
Fierce Biotech
News Tags:
M&A
Novartis
SP-420
Sideris Pharmaceuticals
Headline:
Novartis grabs an option to buy biotech startup for up to $300M
Do Not Allow Advertisers to Use My Personal information
